To explore the effects of DDP, progesterone, calcitriol, and the combination of the two on ovarian and endometrial cancer cells, proliferation and the expression of SMAD2/3 were assessed in control and treated cells in the presence or absence of TGF-βR1 blocker (LY210961). This evidence concerns the gene TGFBR1 and endometrial cancer.